Copyright
©The Author(s) 2021.
World J Gastrointest Endosc. Aug 16, 2021; 13(8): 336-344
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.336
Published online Aug 16, 2021. doi: 10.4253/wjge.v13.i8.336
Ref. | Study design | Endoscopic modality | n | Quality of life measurement | Quality of life findings |
Cahen et al[18,19] | Randomized clinical trial | ERCP ± ESWL | 19 | SF-36 | Physical health: 31 ± 8 to 38 ± 9 (2 yr) and 43 ± 11 (7 yr); Mental health: 33 ± 8 to 40 ± 9 (2 yr) and 46 ± 9 (7 yr) |
Issa et al[20] | Randomized clinical trial | ERCP ± ESWL | 44 | SF-36 | Physical health: 31 ± 8 to 36 ± 9; Mental health: 36 ± 11 to 41 ± 11 |
Stevens et al[31] | Randomized study | Celiac plexus block | 40 | SF-12 | Change in physical score: -0.2 ± 7.5 (triamcinolone + bupivacaine), 1.7 ± 8.8 (bupivacaine); Change in mental score: 1.3 ± 10.0 (triamcinolone + bupivacaine), -2.1 ± 12.9 (bupivacaine) |
Brand et al[22] | Prospective study | ERCP + ESWL | 48 | EORTC | Pain: 37.8 (range 0-81.5) to 18.8 (range 0-83.3); Weight loss: 66.7 (range 0-100) to 0 (range 0-100); Global quality of life: 41.7 (range 16.7-100) to 58.3 (range 8.3-100) |
Hu et al[24] | Prospective study | ERCP + ESWL | 214 | SF-36 | Physical health: 56.9 ± 18.7 to 59.2 ± 14.8 (no significant difference); Patients with pseudocysts: 95 (range 35-100) to 100 (range 75-100); Mental health: 52.2 ± 21.5 to 58.5 ± 16.4; Patients with pseudocysts: 68 (range 36-100) to 76 (range 28-100) |
Milovic et al[27] | Prospective study | ERCP + ESWL | 32 | 1-5 scale | 4 (range 2-5) to 2.5 (range 1-4) |
Basiński et al[32] | Prospective study | Celiac plexus block | 92 | EORTC | Quality of life significantly improved with greatest improvement seen in those with high religiosity |
Rutter et al[21] | Retrospective study | ERCP | 150 | EORTC | Patients treated with surgery had less nausea/vomiting compared to those treated with endoscopy |
Tandan et al[23] | Retrospective study | ERCP + ESWL | 636 | 1-10 scale | 252 (92.6%) patients had improved quality of life |
Seven et al[26] | Retrospective study | ERCP + ESWL | 120 | 1-10 scale | 3.7 ± 2.4 to 7.3 ± 2.7 |
Gerges et al[28] | Retrospective study | Pancreatoscopy-guided lithotripsy | 20 | Generic quality of life instrument | 89% had no or only mild disability in daily activities, 47% had “excellent” or “very good” general health |
Vitale et al[29] | Retrospective study | Minor papilla stenting | 32 | Generic quality of life survey | 100% stated improved quality of life, 100% stated satisfaction with treatment |
- Citation: Han SY, Papachristou GI, Shah RJ, Conwell DL. Effect of pancreatic endotherapy on quality of life in chronic pancreatitis patients: A systematic review. World J Gastrointest Endosc 2021; 13(8): 336-344
- URL: https://www.wjgnet.com/1948-5190/full/v13/i8/336.htm
- DOI: https://dx.doi.org/10.4253/wjge.v13.i8.336